RNA 测序市场：第 2 版

测序市场继续提供强大的工具，具有彻底改变医学的潜力。在过去的十年中，产品推出、新应用程序和急于进入这些新领域的最终用户实验室出现了爆炸性增长。近年来，随着 RNA 测序的不断取代和取代，用于 RNA 表达分析的微阵列的使用显着下降。

本报告侧重于 RNA 测序产品（硬件、硬件服务、软件和消耗品，包括测序步骤本身）市场，讨论趋势、挑战、战略、公司和产品。提供市场份额和收入增长的估计。

调查详情：

• RNA 测序市场 (2021/2026)
• RNA 测序耗材市场 (2021/2026)
• RNA测序设备相关服务市场（2021、2026）
• RNA测序软件市场（2021/2026）
• RNA 测序供应商份额
• 已上市产品
• 软件产品
• 创新
• 临床测序和上市产品

内容

第 1 章执行摘要

第 2 章市场趋势

• 简介
• 趋势
• 用于临床诊断和临床研究
• 癌症 - 白血病/血液病、实体瘤
• 感染
• 罕见的遗传/遗传疾病
• COVID-19
• 多样化的 Illumina 产品组合
• 来自其他公司的 NGS 产品和技术
• CDC SPHERE 联盟
• 不断推出新产品
• 单细胞 RNA 测序
• 主要产品/技术
• 软件/生物信息学
• 多个领域的合作、收购和交易

第三章市场分析

• 市场分析
• 市场份额

第四章公司简介

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

• improved sensitivity and dynamic range

• ability to study species without reference

• measurement of focal changes (such as single nucleotide variants, insertions and deletions)

• detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, “The Market for RNA Sequencing, 2nd Edition ”, focuses on the market for RNA sequencing products - the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

• RNA Sequencing Market, 2021 and 2026

• RNA Sequencing Consumables Market, 2021 and 2026

• RNA Sequencing Equipment-Related Services Market, 2021 and 2026

• RNA Sequencing Software Market, 2021 and 2026

• RNA Sequencing Vendor Share

• Products on The Market

• Software Products

• Innovations

• Clinical Sequencing and Products on the Market

The competitive situation, deals, and litigation are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

• Illumina
• Agilent
• 10X Genomics
• Oxford Nanopore
• Thermo
• Roche
• Qiagen
• and Others

Table of Contents

Chapter 1: Executive Summary

• Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
• Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
• Scope and Methodology
• Report Structure

Chapter 2: Market Trends

• Introduction
• Trends
• Clinical Diagnostics, Clinical Research Applications
• Cancer - leukemia/ hematological diseases; solid tumors
• Infectious diseases
• Rare inherited/ genetic diseases
  • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
• COVID-19
• Illumina's Diverse Range of Products
• Other Companies' NGS Products and Technologies
• CDC's SPHERES Consortium
• Ongoing Introductions of New Products
  • Table 2-2: RNA-Sequencing Product Introductions, August 2017- August 2022
• Single-Cell RNA Sequencing
• Selected Products/ Technologies
  • Table 2-3: Selected RNA-Seq Products and Technologies
• Software/ Bioinformatics
  • Table 2-4: Selected RNA-Seq Software and Related IT Tools
• Partnerships, Acquisitions, Deals in Many Areas
  • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals

Chapter 3: Market Analysis

• Market Analysis
  • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (percent)
  • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
• Market Shares
  • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2021 (millions of dollars and percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
  • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
  • Figure 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

Chapter 4: Company Profiles

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools